Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
- Chemical Structure - duloxetine 01
- Figure 1 - duloxetine 02
- Figure 2 - duloxetine 03
- Figure 3 - duloxetine 04
- Figure 4 - duloxetine 05
- Figure 5 - duloxetine 06
- Figure 6 - duloxetine 07
- Figure 8 - duloxetine 08
- Figure 9 - duloxetine 09
- Figure 10 - duloxetine 10
- Label Image - lbl504360747
- Label Image - lbl504360748
Product Label Images
The following 12 images provide visual information about the product associated with Duloxetine Delayed-release NDC 50436-0747 by Unit Dose Services, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
The text describes a graph displaying the proportion of patients experiencing a relapse over time. The x-axis shows the time from randomization to relapse measured in days, while the y-axis shows the proportion of patients with relapse. Two treatments are compared: placebo and Duloxetine delayed-release capsules. The graph suggests that the treatment with Duloxetine may reduce the risk of relapse compared to placebo.*
Figure 2 - duloxetine 03
The given text seems to be a graph showing the Proportion of Patients with Relapse over time for two treatments - Placebo and Duloxetine delayed-release capsules. Time is represented in days and the proportion of patients is represented on the y-axis. The graph shows that patients on Duloxetine have a lower proportion of relapse over time compared to Placebo.*
Figure 3 - duloxetine 04
Figure 4 - duloxetine 05
Figure 5 - duloxetine 06
Figure 6 - duloxetine 07
Figure 8 - duloxetine 08
The text provides statistical data on the percentage of patients who have experienced improvement while taking placebo and DUL 60/120 mg once daily. The numbers "8 8 8 38 38 3 8 8 8" and "3" may represent the percentage of improved patients in different trials or time points. The graph shows the percent improvement in pain from baseline for different dosage levels ranging from 0 to 100. Therefore, this text could be useful for doctors or researchers who are evaluating the effectiveness of DUL for pain management.*
Figure 9 - duloxetine 09
The text describes a graph showing the percentage of patients improved after taking a placebo or 60mg of DUL once daily. The graph has 10 data points ranging from 50 to 100 on the X-axis and percentages on the Y-axis, with the placebo data represented by the symbol 'X' and the DUL data represented by '&'.*
Figure 10 - duloxetine 10
This text presents a graph showing the percentage of patients who improved after taking either a placebo or DUL60/120 mg once daily medication. The x-axis presents different percentages from 0 to 100, while the y-axis represents different levels of improvement from 0 to 80. Additionally, there is a chart with different values ranging from 0 to 10D. It seems to be related to the percentage of pain improvement from baseline, represented in BOCF.*
Label Image - lbl504360747
This is a description of a drug called Duloxetine Hydrochloride, in the form of delayed-release capsules, with a strength of 30 mg, and packed in a container. Each capsule contains 337 mg of Duloxetine Hydrochloride, which is equivalent to 30 mg of Duloxetine. The drug has a warning to keep it out of reach of children and store it at 25°C. The user should refer to the package insert for dosage information. The manufacturer is Breckenridge Pharm, located in Berlin, CT, with NDC and MFGLOT numbers provided. The text contains duplicates of the same information and is noisy, but can be interpreted as a pharmaceutical description.*
Label Image - lbl504360748
This is a description of a medication with NDC code 50436-074. The medication contains Duloxetine Hydrochloride, which is a delayed release capsule with 60mg per 30 capsules. It is manufactured by Breckenridge Pharma Inc (Berlin, CT). There are dosage instructions on the package insert and should be stored at controlled room temperature. The expiration date is labeled as XUDOXDX, and it is RX only. The rest of the text is not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
